News tagged with adverse events
Related topics: patients , food and drug administration , clinical trials
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Medications
May 22, 2013 |
not rated yet |
0
Study shows low rate of late lumen loss with bioresorbable DESolve device
The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...
Cardiology
May 22, 2013 |
not rated yet |
0
When will genomic research translate into clinical care—and at what cost?
Genomic research is widely expected to transform medicine, but progress has been slower than expected. While critics argue that the genomics "promise" has been broken – and that money might be better spent elsewhere—proponents ...
Genetics
Jan 04, 2013 |
not rated yet |
0
|
Supplement mixture improves memory in mild Alzheimer's
(HealthDay) -- A supplement mixture (Souvenaid) containing dietary precursors and specific nutrients can improve memory in drug-naive patients with mild Alzheimer's disease (AD), according to a study published ...
Alzheimer's disease & dementia
Jul 12, 2012 |
4 / 5 (3) |
1
|
Monthly shot lowers cholesterol 66 percent: study
A monthly injection of an experimental drug made by the US biotech firm Amgen reduced patients' cholesterol by up to 66 percent, according to a small study described at a US cardiology conference.
Cardiology
Mar 26, 2012 |
5 / 5 (2) |
5
Statin alternative looks promising in early trials
(HealthDay) -- Administration of REGN727, a monoclonal antibody to proprotein convertase subtilisin/kexin 9 (PCSK9), significantly reduces low-density lipoprotein (LDL) cholesterol levels, according to the ...
Cardiology
Mar 22, 2012 |
3 / 5 (1) |
1
|
High doses of saw palmetto appear safe over 18 months
(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.
Diseases, Conditions, Syndromes
Apr 29, 2013 |
5 / 5 (1) |
0
SSRIs in perioperative period associated with higher risk for adverse events
Selective serotonin reuptake inhibitors (SSRIs) – among the most widely prescribed antidepressant medications – are associated with increased risk of bleeding, transfusion, hospital readmission and death when taken around ...
Cardiology
Apr 29, 2013 |
not rated yet |
0
Flu vaccine safe for children with IBD, study shows
Influenza immunization rates in children with inflammatory bowel disease (IBD) are low despite its safety according to a new study by researchers at the Institute for Clinical Evaluative Sciences (ICES), Children's Hospital ...
Pediatrics
May 06, 2013 |
not rated yet |
0
First US embryonic stem cell trial is halted
The first-ever trial using human embryonic stem cells to treat paralysis has been halted due to high costs and the company will focus instead on new cancer treatments, Geron said Tuesday.
Medical research
Nov 15, 2011 |
2.5 / 5 (4) |
2
Commercial weight loss programme evaluated
(Medical Xpress)—Anyone who wants to lose weight has a wide variety of diets to choose from, but knowledge of what works is often poor. Researchers at Karolinska Institutet and Uppsala University have now evaluated a Swedish ...
Overweight and Obesity
Sep 20, 2012 |
not rated yet |
0
Contact lens sensor measures 24-hour intraocular pressure
(HealthDay) -- A contact lens sensor (CLS) provides safe and tolerable 24-hour monitoring of intraocular pressure (IOP) patterns in patients with or suspected of having glaucoma, according to research published ...
Ophthalmology
Aug 15, 2012 |
5 / 5 (1) |
0
MS patients did not benefit from CCSVI intervention
The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation ...
Neuroscience
Mar 15, 2013 |
not rated yet |
0
|
Statins are unlikely to prevent blood clots, analysis finds
Despite previous studies suggesting the contrary, statins (cholesterol-lowering drugs) may not prevent blood clots (venous thrombo-embolism) in adults, according to a large analysis by international researchers published ...
Cardiology
Sep 18, 2012 |
3 / 5 (2) |
1
|
Study shows mirabegron effective and well tolerated for overactive bladder
In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with ...
Diseases, Conditions, Syndromes
Mar 04, 2013 |
not rated yet |
0
